Reaction Details |
| Report a problem with these data |
Target | Kappa-type opioid receptor |
---|
Ligand | BDBM21130 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1659529 (CHEMBL4009141) |
---|
Ki | 0.970000±n/a nM |
---|
Citation | Soeberdt, M; Molenveld, P; Storcken, RP; Bouzanne des Mazery, R; Sterk, GJ; Autar, R; Bolster, MG; Wagner, C; Aerts, SN; van Holst, FR; Wegert, A; Tangherlini, G; Frehland, B; Schepmann, D; Metze, D; Lotts, T; Knie, U; Lin, KY; Huang, TY; Lai, CC; Ständer, S; Wünsch, B; Abels, C Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective¿-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo. J Med Chem60:2526-2551 (2017) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Kappa-type opioid receptor |
---|
Name: | Kappa-type opioid receptor |
Synonyms: | Kappa Opioid Receptor | OPIATE Kappa | OPRK1 | OPRK_CAVPO | Opiate Kappa 1 | mu/kappa opioid receptor |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 42744.99 |
Organism: | Cavia porcellus (domestic guinea pig) |
Description: | P41144 |
Residue: | 380 |
Sequence: | MGRRRQGPAQPASELPARNACLLPNGSAWLPGWAEPDGNGSAGPQDEQLEPAHISPAIPV
IITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYL
MNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINI
CIWLLSSSVGISAIILGGTKVREDVDIIECSLQFPDDDYSWWDLFMKICVFVFAFVIPVL
IIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFIICWTPIHIFILVEALG
STSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPIKMRMERQSTSRV
RNTVQDPAYMRNVDGVNKPV
|
|
|
BDBM21130 |
---|
n/a |
---|
Name | BDBM21130 |
Synonyms: | N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide | N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4,5)dec-8-yl)benzeneacetamide | U-69593 | U69,593 | [3H]U69593 |
Type | radiolabeled ligand |
Emp. Form. | C22H32N2O2 |
Mol. Mass. | 356.5017 |
SMILES | CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1)C(=O)Cc1ccccc1 |
Structure |
|